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Modulation of Suppressor Mechanism in Allergic Contact Dermatitis 
IV. Selective Inhibition of Suppressor T-lymphocytes by Serum Obtained from 
Corynebacterium parvum Treated Mice 
J. KNOP, M.D. PH.D., R. RIECHMANN, CAND. MED., AND E. MACHER, M.D. 
Department of Dermatology, University of Miinster, West Germany 
We have previously shown that Corynebacterium par-
VUTn treatment reduced tolerance induced by intrave-
nous injection of 2,4-dinitrobenzene sulfonic acid 
(DNBS03) or by sensitizing BALB/c mice with a supra-
optimal dose of 2,4-dinitrofluorobenzene (DNFB). 
Further analysis by transfer experiments revealed 
that the generation and/or functional expression of sup-
pressor T -Iymphocytes (T.-cells) was inhibited in both 
tolerance models. Inhibition of T.-cells was not entirely 
correlated with suppression of mitogen induced lympho-
cyte proliferation mediated by C. parvum activated mac-
rophages. 
In this investigation we studied the effect of serum 
obtained at various times after C. parvum injection on 
tolerance and T.-cells in DNFB contact allergy. Serum 
obtained 6 and 24 hr, however, not 72 hr after C. parvum 
injection inhibited T.-cells, induced by DNBS03 and 
tested by transfer to naive recipients, as efficiently as C. 
parvum itself. 
The serum had following characteristics: (1) It in-
hibited the functional expression of T. in the recipient 
animal. (2) It inhibited tolerance induction by an epicu-
taneous supra~optimal dose of DNFB. (3) It did not in-
hibit the induction and functional expression ofT-effec-
tor cells of delayed hypersensitivity (TDII-cells) as shown 
by transfer experiments. (4) The T . -inhibitory factor was 
heat resistent (56°C), not destroyed or lost by dialysis 
against tris-glycine buffer pH 2 and could not be detected 
in the serum of NMRI-mice injected 24 hr before with C 
parvum. (5) The C parvum serum did not significantly 
increase the spleen weight or suppress mitogen-induced 
spleen lymphocyte proliferation. 
The nature of this T.-cell inhibitory factor is unknown, 
although the results suggest that cortisone or transfer 
of bacteria are not responsible. Factors mediating selec-
tive inhibition ofT.-cells may be of important regulatory 
function in delayed type hypersensitivity. 
We have previously shown that the diminished contact al-
lergic response induced by applying an increased amount of 2,4-
dinitrofluorobenzene (DNFB) on the shaved abdominal skin of 
BALB/c mice (antigen overload [1]) can be enhanced by prior 
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treatment of the mice with Corynebacterium parvum (C par-
vum [2]). Further analysis of this phenomenon demonstrated 
that this effect is due to a preferential suppression of T-sup-
pressor cells (Ts-cells) by C.parvum [3]) . The T s-cell inhibitory 
effect 'partially correlated with the suppressive effect of C 
parvum activated spleen macrophages on mitogen induced 
lymphocyte proliferation (Knop et al, unpublished observa-
tion) ; maximal suppression of lymphocyte proliferation was 
observed 1- 3 weeks after C parvum injection; optimal inhibition 
of suppressor T-cell activity was obtained immediately or 1-2 
weeks after C parvum injection. This pointed to a factor(s) 
released early after C parvum injection, possibly by macro-
phages or other cells. In the following study we looked for a 
factor released into the serum after C parvum injection. It will 
be shown that serum obtained from mice 6 and 24 til" after C 
parvum injection inhibited suppressor T-cell generation and/ or 
functional expression with similar efficiency as C parvum itself. 
A 72 hr serum, however, was not effective. We further studied 
the effect of this serum on T s-cell generation and function and 
T -effector lymphocyte (T DH) induction and function. It was 
found that this serum selectively .inhibited T s-cells with no 
suppressive effect on TDH-cells. 
MATERIALS AND METHODS 
Mice 
BALB/ c mice were purchased from the Zentralinstitut fur Versuchs-
tierzucht, Hannover, FRG, kept under conventional conditions and 
used at the age of 10-12 weeks. For the production of C parvum serum 
5-6 mo old BALB/ c and outbred white mice (NMRI, Hannover, FRG) 
were used. 
Reagents 
C parvum (7 mg/ mi, lot CA 761), heat inactivated, was obtained 
from Wellcome Research Laboratories, Beckenham, England. 2,4-din-
itrofluorobenzene (DNFB) and 2,4-dinitrobenzene sulfonic acid 
(DNBSO:lNA) were obtained from Sigma Chemical Company, 
Munchen, FRG. Serum was dialyzed for 48 hr against glycine-HCI 
buffer pH 2.0 (14.175 g glycine 70 ml, 1 normal HCI in 5 1 aqua dest. 
and adjusted with 1 normal HCI to pH2). 
Sensitization and Elicitation of DNFB Contact Sensitivity 
This has been described in detail [2, 4). In short: the mice were 
sensitized with DNFB (15 MI 0, 5% or in some experiments with 50 JLI 
DNFB 0, 5%) by 2 daily abdomal paintings. The ear was painted on the 
dorsum with 0.3% DNFB on day 5 and ear thickness measured 24 hI" 
later. Tolerance was induced by intravenous (i.v.) injection of 15 mg 
DNBS03NA 6 days before sensitization attempts [3, 5]. The results al'e 
also expressed as percent tolerance 
=1- xl . ( 
expo value - negative control) 00 
positive control - negative control 
Preparation and Transfer of T ,- and Tim-Lymphocytes 
For T.-cell transfer spleen cell suspensions were prepared from mice 
6 days after i.v. injection of 15 mg DNBS03 [2, 4]. For TDwlymphocyte 
transfer spleen cells were prepared from mice 3 days after the last 
sensitization with 15 JLI DNFB 0.5% [3]. Preparation of the spleen cells 
and the media used have been described; 1 x lOs cells/mouse from 
tolerized or sensitized donors were injected i.v. 
469 
470 KNOP, RIECHMANN, AND MACHER 
Lymphocyte Proliferation Assay 
This has been described previously [6]. In short, 4 X lOr. spleen cells 
from C parvum or C parvum serum treated or untreated animals were 
cultured in the presence of concanavalin A (Con A, 10 J.Lg) for 48 h in 
micro titer culture plates, whereby 3H-thymidine (0.5 J.LCi/well, Amer-
sham Buchler) was added for the last 16 hr. 
The results are expressed in counts per minute ± standard deviation 
(cpm ± SD) of triplicate cultures. 
DNBS03iv 










measur. of ~ ear challenge ~eQr swelling ~ ..... ~ 9NFB 0,3%) r'~ / 
~ 24hrs ~
FlG 1. Experimental design. 
Statistical Analysis 
AU data are expressed as mean ± standard deviation (SD) and were 
analyzed by an one-way analysis of variants followed by Scheffe's test 
for least significant difference. 
RESULTS 
In Fig 1 the experimental design of the basic experiment is 
illustrated. In a fIrst series of experiments serum obtained 6, 24 
and 72 hr after e parvum injection (2.8 mg/mouse) was injected 
i.v. prior to tolerance induction; spleen cells were transferred 
and T .-cells assayed as shown in Fig l. After injection of 1 rnl 
6 or 24 hr e parvum serum no T s-cells could be demonstrated 
in the recipients (Fig 2 e, D), serum obtained 72 hr after e 
parvum injection and normal serum had no effect 011 T s-cells 
(Fig 2E, F). In the experiments illustrated in Fig 3 we studied 
the effect of various doses of e parvum serum on T s-cells. 
Groups of mice were injected i.v. 2 hr after tolerization with 1 
rnl, 0.5 ml and 0.1 rnl e parvum serum. Six days later the spleen 
cells were removed and T s-cell activity assessed in the recipient 
animal. From the group treated with 1 rnl e parvum seru·m no 
T s-cells could be transferred (Fig 3 e), injection of 0.5 rnl of e 
parvum serum was less and 0.1 rnl was not effective (group D 
and E). Usually the serum was injected 2 hr after tolerization, 
however, i.v. injection of 1 rnl e parvum serum 6 days before 
tolerization was similarly effective (Fig 3, group G). In all 
experiments described below, serum obtained 24 hr after e 
parvum injection was used. 
In the following experiments described in Fig 4 the effect of 
e parvum serum on T .-cell function was investigated. For this 
purpose mice receiving T s-cells from tolerized donors were 
treated with e parvum serum 2 hr after spleen cell transfer. As 
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FlG 2. Inhibition of T. generation by BALB/c C parvum serum 
obtained at different times after C parvum injection (2.8 mg/ mouse). 
1 ml of C parvum serum or normal serum was injected i.v. before i.v .-
injection of 15 mg DNBS03/ mouse. Six days later spleen cells from 
these mice were transferred to normal recipients which were sensitized 
and challenged with DNFB as described. Ear swelling was assessed 24 
hr after challenge. Bar represent 2 X standard deviation of the mean 
in this and subsequent figures. A = Positive control (optimal sensitized 
animals). B = Spleen cell transfer from tolerized donors. C = Donor 
treated with 6 hr C parvum serum 2 hr before DNBSO, i.v. D = Donor 
treated with 24 hr C parvum serum 2 hr before DNBSO" i.v. E = Donor 
treated with 72 hr C parvum serum 2 hr befor·e DNBS03 i.v. F = Donor 
treated with normal BALB/c serum 2 hr before DNBS03 i.v. G = 
Negative control (nonsensitized animals, challenged) . Stat. analysis: n 
= 8 - 10 mice per group: C increased over B(p < 0.01); D increased 













FIG 3. Dose dependence of T,-cell inhibitory effect of C parvum 
serum. Various amounts of C parvum serum obtained from BALB/c 
mice 24 hr after injection of C parvum (2.8 mg/mouse) were injected 
i.v. 2 hr after DNBSO" (15 mg/mouse) injection. Six days later spleen 
cells were transferred to naive recipients and the suppressor function 
tested as described. A = Positive control. Ear swelling of recipients 
after transfer of spleen cells from B = tolerized animals. C = Animals 
pretreated with 1 ml C parvum serum before tolerization. D = Animals 
pretreated with 0.5 rnl C parvum serum before tolerization. E = Animals 
pretreated with 0.1 rnl C parvum serum before tolerization. F = Animals 
pretreated with 1 rnl normal BALB/c serum before tolerization. G = 
Animals pretreated with 1 ml C parvum serum 6 days before toleriza-
tion. H = negative control. Statistical analysis: n = 8 - 10 animals per 
group: B decreased from A (p :s 0.01); C increased over B) p < 0.01) ; D 
not different from C and E; F decreased from C(p < 0.01); G increased 
over Band F(p < 0.01). 
cells-although less efficiently-in the recipient animals after 
spleen cell transfer from tolerized donors. 
In F'ig 5 experiments are shown in which tolerance was 
induced by antigen overload as described previously [1, 2]. 











A 8 c o 
o cS 100 
FIG 4. Effect of C parvum serum on T,-cell function in the recipient. 
Two hours after T,-cell transfer from tolerized animals 1 ml of C 
parvum serum (24 hr serum) was injected i.v. T,-cell function was 
tested as described. A = Positive control. Ear swelling of recipients 
after spleen cell transfer from B = Tolerized donors. C = Tolerized 
donors, recipient injected with 1 ml C parvum serum. D = Negative 
control. Statistical analysis: n = 7 - 11 animals per group: B decreased 















FIG 5. Effect of 24 hr C parvum serum on tolerance induced by 
antigen overload. BALB/c mice were sensitized with a supraoptimal 
dose (50 pl, 0.5%) of DNFB twice and contact reaction elicited after 5 
days as usual. A = Positive control (sensitized with 15 III DNFB 0.5%). 
B = Animals sensitized with 50 pl DNFB 0.5%. C = C parvum serum 
injected 2 hr after sensitization with 50 Itl DNFB 0.5%. D = Negative 
control. 
significantly reduced response (Fig 5, group B). Injection of 1 
rnl C parvum serum 6 days before sensitization with 50 /-tl 
DNFB abolished the tolerizing effect of the antigen overload 
(Fig 5, C), the contact allergic response was now similar to that 
found in the normal positive control sensitized with an optimal 
amount of DNFB (15 JJl, group A). 
Previous results suggested that, although C parvum treat-
ment inhibited T s-cells, such a treatment had only little effect 
on T owcells. The following experiment was designed to study 
the effect of C parvum serum on the induction and function of 
Towcells by adoptive transfer. For this purpose mice were 
sensitized and 3 days after sensitization spleen cells from these 
mice were transferred to naive recipients which were then 
challenged at the same day of spleen cell transfer on the right 
ear. The contact reaction was measured 24 hr later. As shown 
in Fig 6, contact reactivity could be transferred from sensitized 
animals to naive recipients (group B). Injection of the donors 
with 1 mI C parvum serum 2 hr (Fig 6, group C) or 6 days 
(group D) before the first sensitization had no effect on the 
induction of T owcells. Similarly, the recipients of the spleen 
cells· from sensitized donors treated 2 hr (group E) or 6 days 
(group F) before spleen cell transfer with 1 ml C parvum serum 
showed a normal contact reaction as compared with untreated 
recipients of T owcells from sensitized donors (Fig 6, group B). 
In Fig 7 some characteristics of the 24 ill' C parvum serum 
which inhibits T s-cells are shown. No significant loss of Ts-cell 
inhibitory activity was observed in the serum after heating for 
45 min at 56°C (group E, Fig 7) and after dialysis for 2 days 
against HCI-glycine buffer pH 2 (group F, Fig 7) most of the 
activity could be recovered. A serum obtained from NMRI mice 
24 hr after C parvum injection had no Ts-cell inhibitory activity 
(Fig 7, group H) . 
In the Table the effect of C parvum and C parvum-serum on 
spleen weights and spleen lymphocyte proliferation induced by 
Con A are shown. Injection of C parvum increased the spleen 
weights cpnsiderably at days 7, 14, and 21 and suppressed 
lymphocyte proliferation at the same days. C paruum serum 
had no significant effect on spleen weights and lymphocyte 
proliferation. 
DISCUSSION 
The immune response in contact allergy can be modulated 
by selectively inhibiting the generation and/or function of Ts-
earswelling sensitisation 
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FIG 6. Effect of 24 hr C parVllln serum on TDB-cells. BALB/ c mice 
were sensitized with an optimal dose of DNFB (15 Ill , 0.5%) and 4 days 
later spleen cells were transferred from these mice to un treated recip-
ients. Two hours later the recipients were painted on the right ear with 
20 III 0.3% DNFB and ear swelling measW'ed 24 hr later. A = positive 
control. B-F = Ear swelling in recipients injected i.v. with spleen cells 
(1 X 108 cells) from sensitized donors. B = Donors untreated. C = 
Donors treated with 1.0 ml 24 hr C pa.rvum serum 2 hr before sensiti-
zation. D = Donors treated with 1.0 ml C parvurn serum 6 days before 
sensitization. E = Recipients treated with C pa.rvum serum 2 hI' after 
spleen cell transfer. F = Recipients treated with C parvum serum 6 
days before spleen cell transfer. G = Negative control. Statistical 
analysis: n = 8 - 11 animals per group: B increased over G(p < 0.01); 
C, D, E, F not different from B. 
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FIG 7. Effects of various treatments of 24 hr C parvum serum on its 
T ,-inhibitory activity. For experimental design see Fig. 1. Donors ofT.-
cells were treated with C parvum serum 2 hr before i.v. injection of 
DNBSO;j. A = Positive control. B = Positive control, treated with 1.0 
ml C parvum serum 2 hr before sensitization. Ear swelling in recipients 
after transfer of spleen cells from tolerized donors C = Untreated. D 
= Treated with 1.0 ml C parvum serum. E = Treated with 1.0 ml C 
parvum serum, heated for 45 min, 56°C. F = Treated with l.0 ml C 
parvum serum, dialyzed for 2 days at pH 2. G = Treated with 1.0 ml 
normal BALB/c serum. H = Treated with 1.0 ml C parvum NMRI 
serum. I = Negative control. Statistical analysis: n = 8 - 10 mice per 
group: A not different from B; C decreased from A, D, E, F(p < 0.01) ; 
G, H not different from C. 
Effect of C parv.um and C parvum serum (24 hr serum) on spleen 
weight and spleen lymphocyte proliferation. C parvum and C 
parvum serum were tested in different experiments 
Day after 
Cparvum C parvum-serum 
(2.8 mg) Lp. i.v. (1.0 ml) 
Treatment 
s.w.n s.c.pro!. · s.w. n s.c .prol. h 
Untreated 134 ± 8" 30 ± 4 166 ± 31" 15 ± 4" 
1 122 ± 19 28 ± 3 174 ± 24 20 ± 3 
7 423 ± 97 8±2 185 ± 15 18 ± 4 
14 858 ± 119 5±2 177 ± 15 12 ± 3 
21 360 ± 105 15 ±3 184 ± 25 n.d. 
28 234 ± 100 26 ± 3 n.d. n.d . 
35 234 ± 47 n.d. n.d. m.d. 
" Spleen weights in mg ± SD of 5 animals. 
b Spleen cell proliferation induced by Con A in cpm (XlO- ") ± SD of 
5 animals. n.d. = not done. 
cells by C parvum. This has been shown in various models 
which generate Ts-cells [2, 3]. 
Serum obtained 6 and 24 hr, however, not 72 hr after C 
par,!um injection, was similarly inhibitory on T .-cells as C 
parvum itself. 
The following characteristics of the factor in the C parvum 
serum have been obtained. (1) It inhibited the generation of 
functionally active Ts-cells and, less efficiently than C parvum, 
the functional expression of Ts in the recipients. Ts-inhibition 
has been demonstrated in 2 T .-cell models: in model AT. nff (T. 
suppressing the afferent limb of the immune response) ;rre 
generated by i.v. injection ofDNBS03 according to Phanuphak, 
Moorhead, and Clam an [4,5], in model B T. nrr and THre-cells 
(Ts suppressing the efferent limb) are generated by an epicu-
taneous antigen overload [1,7]. This suggests that the target 
cell(s) is the T sllrr and possibly also T serf; however, this awaits 
further analysis. The serum factor mediating inhibition appears 
to be in the serum in a very limited amount, i.e., injection of 0 .5 
ml of the serum had still some effect, however, injection of 0.1 
ml had no effect on suppressor cell induction. It might be 
possibl.e that efficient inhibition of the functional expression of 
T. requires higher concentrations of such a factor. (2) The C 
parvum serum had no effect on the induction and function of 
Towcells as assessed by transfer experiments. This does not 
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exclude that the amount of active factor mediating inhibition 
of Ts may be too low to inhibit TDli . Indirect evidence for this 
is provided by the finding that C parvum injected shortly before 
sensitization inhibits the contact allergic response [2). 
This result suggests that a certain subpopulation of lympho-
cytes with antigen specific suppressive function is particularly 
sensitive to a serum factor produced or released by C parvum. 
The mechanism ofT. inhibition is unclear. The experiments do 
not allow to distinguish between generation of Ts cells and 
inhibition of the function of generated Ts-cells. The factor may 
act by inhibition of Ts proliferation; proliferation of lympho-
cytes is inhibited by a number of factors such as prostaglandin 
[8], interferon [9] and other factors released by macro phages 
and/or lymphocytes after C parvum injection [10, ll]. Although 
the serum had no significant effect on spleen weight and mito-
gen induced lymphocyte proliferation [12], a selective inhibition 
of T s proliferation may still be possible. Other possibilities are 
inhibition of the functional expression of generated T .-cells or 
preactivation and proliferation ofTs-celis by a bacterial mitogen 
present in the serum resulting in a paralysis of the antigen 
specific Ts-cell function. An improvement of the antigen pre-
senting function of macro phages by the serum factor with more 
active TDwcelis overcoming Ts cell actively seems to be unlikely 
since no TDwcells can be demonstrated by transfer from toler-
ized animals (pretreated or nonpretreated with C parvum) 
(Knop, unpublished observation). Injection of DNBS03 results 
in the induction of T s cells and clonal inactivation of TDwcells 
[7]. 
Interestingly, the serum had an inhibitory effect on Ts-cells 
also when injected 6 days before the induction of these cells; 
this excludes short-lived factors such as cortisone or prostaglan-
dins; such factors are also excluded by the findings that the 
serum retained its activity after dialysis. This result suggests 
either a long acting factor produced by C parvum activated 
cells or a bacterial factor in the serum which induces a Ts-cell 
inhibitor in the animal or acts otherwise on T s-cells. Simple 
transfer of a biologically active number of bacteria with the 
serum is unlikely, since 24 hr C parvum serum from NMRI-
mice was not active and no significant effect of the serum on 
spleen weight and lymphocyte proliferation was observed. 
The biological significance of these findings can only be 
evaluated in relation to the contact allergy model used to study 
the immune regulatory function of C parvum and C parvum 
serum; the data provided show that a delayed hypersensitivity 
reaction can be facilitated by selective inhibition of the sup-
pressive limb of the immune response as has been described for 
cyclophosphamide [13-15,7). It is intriguing, however, to spec-
ulate that the immune stimulatory effects of C parvum may 
partly be mediated by such a mechanism. 
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Letter to the Editor 
To the Editor: 
We want to add additional information to our abstract "Ehlers-Danlos (ED) type VIII skin has a 
reduced proportion of collagen type III" presented at the XI meeting of the Emopean Society for 
Dermatological Research (Invest Dermatol 76: 422, 1981) . 
Very recently we had a chance to collect a new biopsy in our patient. In this larger sample from the 
inner face of the thight collected 4 yr after the first biopsy that was from the inner side of the arm we did 
not find the reported reduced proportion of collagen type III, neither in the isotonic saline nor in the 
pepsin extract. We have no valid explanation for this discrepancy. 
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